文献速递瓣膜外科先天性心脏病外科

新生儿、婴儿与儿童主动脉瓣修复:系统综述、Meta分析与微观模拟研究

Aortic valve repair in neonates, infants and children: a systematic review, meta-analysis and microsimulation study.
PubMed 文献 · Eur J Cardiothorac Surg · 2023-01-01

该系统综述纳入1990年1月1日至2021年12月23日发表的41篇文献、2623例患儿(随访17217患者年),汇总儿童、婴儿、新生儿主动脉瓣修复后的早期事件风险、晚期事件率及时间-事件数据,并用微观模拟模型模拟个体化终身结局。结果显示修复时年龄越小,早期死亡率与晚期再干预率越高,但瓣膜相关事件发生率低,长期结局满意,作者认为儿童主动脉瓣疾病可考虑主动脉瓣修复。

要点

  • 儿童、婴儿、新生儿狭窄修复后汇总早期死亡率分别为3.5%、7.4%和10.7%。
  • 儿童、婴儿、新生儿狭窄修复后晚期再干预率分别为3.31%/年、6.84%/年和6.32%/年。
  • 微观模拟显示儿童、婴儿、新生儿主动脉瓣狭窄修复后20年内平均预期寿命分别为18.4年、16.8年和15.9年。

核心结论

  • 儿童主动脉瓣修复治疗狭窄的长期结局满意,且取决于手术时年龄;尽管瓣膜功能障碍再干预风险高、生存较一般人群略受损,但瓣膜相关事件发生率低,作者认为儿童主动脉瓣疾病应考虑主动脉瓣修复。

研究设计与样本

  • 系统综述与Meta分析,检索1990年1月1日至2021年12月23日发表的报告儿童主动脉瓣修复(手术时平均年龄<18岁)临床结局的文献,纳入41篇出版物、共2623例患者、17217患者年随访(中位随访7.3年,范围1.0-14.4年),并采用微观模拟模型模拟个体患儿终身结局。

主要发现

  • 狭窄修复时汇总平均年龄:儿童(<18岁)5.2±3.9岁,婴儿(<1岁)35±137天,新生儿(<30天)11±6天。
  • 狭窄修复后汇总早期死亡率:儿童3.5%(95%CI 1.9-6.5%),婴儿7.4%(95%CI 4.2-13.0%),新生儿10.7%(95%CI 6.8-16.9%)。
  • 狭窄修复后汇总晚期再干预率:儿童3.31%/年(95%CI 1.66-6.63%/年),婴儿6.84%/年(95%CI 3.95-11.83%/年),新生儿6.32%/年(95%CI 3.04-13.15%/年)。
  • 狭窄修复后汇总晚期心内膜炎率:儿童0.07%/年(95%CI 0.03-0.21%/年),婴儿0.23%/年(95%CI 0.07-0.71%/年),新生儿0.49%/年(95%CI 0.18-1.29%/年);瓣膜血栓率:儿童0.05%/年(95%CI 0.01-0.26%/年),婴儿0.15%/年(95%CI 0.04-0.53%/年),新生儿0.19%/年(95%CI 0.05-0.77%/年)。
  • 微观模拟显示主动脉瓣狭窄修复后前20年平均预期寿命:儿童18.4年(95%可信区间18.1-18.7年;相对生存率92.2%),婴儿16.8年(95%可信区间16.5-17.0年;相对生存率84.2%),新生儿15.9年(95%可信区间14.8-17.0年;相对生存率80.1%);20年再干预风险:儿童75.2%(95%可信区间72.9-77.2%),婴儿53.8%(95%可信区间51.9-55.7%),新生儿50.8%(95%可信区间47.0-57.6%)。

临床怎么用

  • 作者认为儿童主动脉瓣疾病应考虑主动脉瓣修复,长期结局满意且瓣膜相关事件发生率低,但结局取决于手术时年龄,年龄越小早期死亡率与晚期再干预率越高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To support clinical decision-making in children with aortic valve disease, by compiling the available evidence on outcome after paediatric aortic valve repair (AVr). METHODS: A systematic review of literature reporting clinical outcome after paediatric AVr (mean age at surgery <18 years) published between 1 January 1990 and 23 December 2021 was conducted. Early event risks, late event rates and time-to-event data were pooled. A microsimulation model was employed to simulate the lives of individual children, infants and neonates following AVr. RESULTS: Forty-one publications were included, encompassing 2 623 patients with 17 217 patient-years of follow-up (median follow-up: 7.3 years; range: 1.0-14.4 years). Pooled mean age during repair for aortic stenosis in children (<18 years), infants (<1 year) or neonates (<30 days) was 5.2 ± 3.9 years, 35 ± 137 days and 11 ± 6 days, respectively. Pooled early mortality after stenosis repair in children, infants and neonates, respectively, was 3.5% (95% confidence interval: 1.9-6.5%), 7.4% (4.2-13.0%) and 10.7% (6.8-16.9%). Pooled late reintervention rate after stenosis repair in children, infants and neonates, respectively, was 3.31%/year (1.66-6.63%/year), 6.84%/year (3.95-11.83%/year) and 6.32%/year (3.04-13.15%/year); endocarditis 0.07%/year (0.03-0.21%/year), 0.23%/year (0.07-0.71%/year) and 0.49%/year (0.18-1.29%/year); and valve thrombosis 0.05%/year (0.01-0.26%/year), 0.15%/year (0.04-0.53%/year) and 0.19%/year (0.05-0.77%/year). Microsimulation-based mean life expectancy in the first 20 years for children, infants and neonates with aortic stenosis, respectively, was 18.4 years (95% credible interval: 18.1-18.7 years; relative survival compared to the matched general population: 92.2%), 16.8 years (16.5-17.0 years; relative survival: 84.2%) and 15.9 years (14.8-17.0 years; relative survival: 80.1%). Microsimulation-based 20-year risk of reintervention in children, infants and neonates, respectively, was 75.2% (72.9-77.2%), 53.8% (51.9-55.7%) and 50.8% (47.0-57.6%). CONCLUSIONS: Long-term outcomes after paediatric AVr for stenosis are satisfactory and dependent on age at surgery. Despite a high hazard of reintervention for valve dysfunction and slightly impaired survival relative to the general population, AVr is associated with low valve-related event occurrences and should be considered in children with aortic valve disease.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Notenboom ML, Rhellab R, Etnel JRG, et al. Aortic valve repair in neonates, infants and children: a systematic review, meta-analysis and microsimulation study. Eur J Cardiothorac Surg. 2023. PMID: 37584683. doi:10.1093/ejcts/ezad284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。